Case ID: 606052
Solution ID: 12

Genentech Capacity Planning Case Solution

Case Solution

While assisting an intricate clinical approval process within the next 2 to 3 years for any group of new cancer drugs, Genentech must create a lengthy-term capacity arrange for a significant type of new cancer items. Contributing to the complexness and uncertainty is always that charge here we are at planning, building, and validating a brand new $600 million plus production-scale facility is 5 years. Additionally, making certain the best process technologies are integrated into this type of new plant helps make the task facing David Ebersman, the senior vice-leader of items procedures, and the management team a challenging one. Frames the problems Ebersman and the team face and outlines the approach up to now.

Request Case Study Solution

Prepared by MBAs and CFAs according to your requirements



Already Registered? Login here!


Order Summary

SubjectNot Selected
LengthNot Selected
Deadline Not Selected
Estimated Submission On
Total 0